MyHealthChecked PLC (LSE:MHC) reported £0.5 million in revenue for the first half of 2025, a decline from the previous year, while its wellness portfolio grew by 60%. The company has bolstered its market presence through strategic collaborations, notably a major partnership with Boots to supply lateral flow self-tests and laboratory tests under Boots’ Own Brand label.
In addition, integration with Patients Know Best enables test results to be accessed via the NHS App, enhancing customer engagement and supporting future growth. Although COVID test sales have decreased, MyHealthChecked remains optimistic about the long-term potential of its wellness offerings.
About MyHealthChecked PLC
MyHealthChecked PLC is a UK-based healthcare company focused on at-home testing and wellness solutions. It provides a variety of rapid tests and sample collection kits for blood, urine, nasal, or mouth swabs, analyzed by partner laboratories. The company’s mission is to make healthcare more accessible and affordable while capitalizing on the expanding at-home testing market.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Leave a Reply